Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …
News

Roche’s entrectinib shrinks lung tumours with two-year response duration

September 25, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Cancer, NSCLC, NSCLC< lung cancer, Roche, entrectinib

Roche was unveiled new Phase 1 and 2 data for entrectinib in the treatment of locally advanced or metastatic ROS1-positive …
News
astrazeneca_building_white

AstraZeneca chalks up European approval for Imfinzi in locally advanced, unresectable lung cancer

September 25, 2018 Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MedImmune, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as …
News

Working Life: Jean-Christophe Tellier, CEO of UCB Pharma

September 24, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UCB, Working Life, feature

Just as his company announced robust H1 2018 financials, UCB’s Jean-Christophe Tellier spoke to Pharmafocus to share his experiences of …
Feature
6813384933_1fb31d73fb_z

HIV on the rise among straight men in Australia

September 24, 2018 Medical Communications, Sales and Marketing AIDS, Aboriginal, Australia, HIV, Kirby Institute

The number of new HIV diagnoses is on the rise among heterosexual men in Australia, according to a new report …
News
7359dba7-e1da-4eb4-8765-58da6178899b

Sarepta’s Exondys 51 hit with negative CHMP opinion in Duchenne muscular dystrophy

September 24, 2018 Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta

Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …
News

Courts back NHS in fight against Novartis and Bayer

September 24, 2018 Sales and Marketing Bayer, Eylea, NHS, Novartis, avastin, ludentis

The NHS has won a court case against multinational pharmaceutical firms Novartis and Bayer, after the companies sought to block …
News
calvarycemeteryqueens_edit

Life expectancy falls in America; drugs, alcohol and suicide to blame

September 24, 2018 Sales and Marketing USA, alcohol, drugs, health, opiod crisis, suicide

Life expectancy has fallen for the second year in a row for people in the United States, according to new …
News
astrazeneca-sign

AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients

September 24, 2018 Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma

AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …
News
humira_abbott__4

EU approval for Mylan and Fujifilm’s Humira biosimilar

September 21, 2018 Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma

The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week

September 21, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jobs, Novartis, Novo Nordisk, Senate, UCB, manufacturing, opioid crisis, top 10

Manufacturing took a hit this week as Novo Nordisk announced the loss of 400 jobs while Novartis made the move …
News
alzheimers_pharmafocus_accompanying_image

A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated

September 20, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …
Feature
white-house-13863_960_720

Senate bill would save money and allow generics to reach market more quickly, according to CBO report

September 20, 2018 Business Services, Medical Communications, Sales and Marketing CBO, Senate, US, biosimilars, generics, law, politics

The Congressional Budget Office (CBO) has said in a report that a bipartisan bill awaiting a vote in the senate …
News
sicorbio

FDA greenlights Teva’s migraine drug Ajovy in two dosage options

September 20, 2018 Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …
News
merckwindow_web

MSD to launch Keytruda at half US list price in China

September 20, 2018 Business Services, Sales and Marketing BMS, China, MSD, global, keytruda, markets, pricing

US pharma giant MSD will offer cutting edge cancer treatment Keytruda to Chinese patients at half the price at what …
News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026